Robert L Belquist, DDS | |
120 1st St S, New Rockford, ND 58356-1903 | |
(701) 947-2354 | |
(701) 947-2356 |
Full Name | Robert L Belquist |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 120 1st St S, New Rockford, North Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659583813 | NPI | - | NPPES |
40710 | Medicaid | ND |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 1602 (North Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robert L Belquist, DDS 120 1st St S, New Rockford, ND 58356-1903 Ph: (701) 947-2354 | Robert L Belquist, DDS 120 1st St S, New Rockford, ND 58356-1903 Ph: (701) 947-2354 |
News Archive
In the summer of 2010, researchers from Lund University in Sweden reported that 60 per cent of all anterior cruciate ligament (ACL) reconstructions could be avoided in favour of rehabilitation.
The Fukushima Daiichi nuclear disaster spread significant radioactive contamination over more than 3500 square miles of the Japanese mainland in the spring of 2011. Now several recently published studies of Chernobyl, directed by Timothy Mousseau of the University of South Carolina and Anders M-ller of the Universit- Paris-Sud, are bringing a new focus on just how extensive the long-term effects on Japanese wildlife might be.
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma.
Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product CM-AT for autism. CM-AT is presently in Phase III clinical trials at 18 sites around the US.
In what they are calling a new direction in the study of Alzheimer's disease, UC Santa Barbara scientists have made an important finding about what happens to brain cells that are destroyed in Alzheimer's disease and related dementias.
› Verified 4 days ago
Dr. Robert F.w. Cudworth, DDS Dentist Medicare: Medicare Enrolled Practice Location: 708 1st Ave N, New Rockford, ND 58356 Phone: 701-947-2354 Fax: 701-947-2356 | |
Dr. Amy Ellingson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 708 1st Ave N, New Rockford, ND 58356 Phone: 701-947-2354 Fax: 701-947-2356 |